Benign positional vertigo (BPPV) is a sensation of spinning, a form of dizziness. This sensation happens for a few minutes and stops automatically. Benign positional vertigo is related to the labyrinth system which is present inside the inner ear and is responsible for maintaining balance in the body. Sometimes, the free floating particles in the inner ear exert a force to cause benign positional vertigo symptoms. Other causes for benign positional vertigo symptoms include viral infection, nerve inflammation, complications after the ear surgery, side effects of medication and rapid head movement. Nausea, sweating, abnormal eye movements and vomiting are the common symptoms caused by benign positional vertigo. Other symptoms include visual disturbance, hearing loss, and difficulty in speaking and walking. Benign positional vertigo is treated by simple exercises such as Epley maneuver or Brandt–Daroff. Benign positional vertigo treatment is done by the Dix–Hallpike test to determine the posterior semicircular canal involvement and Roll test to check the horizontal semicircular canal involvement. Benign positional vertigo treatment is also done by medications and surgeries. Medication involved in benign positional vertigo treatment by drug class are anti-histamine, anti-cholinergic, and anti-depressant or sedative-hypnotics.
The growing number of cases of benign positional vertigo is driving the growth of the benign positional vertigo treatment market. Rapid turnaround time, lower cost of procedure over conventional methods also fuel the growth of the benign positional vertigo treatment market. Also, the varied application of benign positional vertigo testing procedures in analyzing/tracking the inner ear and central nervous system and increasing adoption of the treatments in the routine check-ups are harnessing the growth of the benign positional vertigo treatment market. However, lack of awareness regarding benign positional vertigo treatments is expected to restrain the growth of the benign positional vertigo treatment market.
Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1292
Benign positional vertigo treatment market: Segmentation
Tentatively, the benign positional vertigo treatment market has been segmented on the basis of the drug class, distribution channel, age group, and geography.
Based on drug class type, the benign positional vertigo treatment market is segmented as:
Based on the distribution channel, the benign positional vertigo treatment market is segmented as:
- Hospital Pharmacy
- Retail Pharmacies
- Drug Stores
- Online Pharmacy
Based on age group, the benign positional vertigo treatment market is segmented as:
Benign Positional Vertigo Treatment Market: Overview
According to the International Headache Society and German National Telephone Health Interview Survey 2003, 243 of 1,003 (24%) participants with moderate dizziness/vertigo had a history of vestibular vertigo and 80 (8%) fulfilled the diagnostic criteria for benign positional vertigo (56 women and 24 men; aged 28–82?years). Lifetime prevalence was 3.2% in females, 1.6% in males and 2.4% overall. Medical consultation for benign positional vertigo treatment was reported by 78% of individuals. The 1?year incidence was calculated as 0.6%. Patients usually are seen to prefer internal/general medicine (82%), otolaryngology (57%) and neurology (47%) for benign positional vertigo treatment. As per an article from the International Headache Society survey 2003, 1.1?million adults suffer from BPPV each year in Germany. Japan reported an incidence of BPPV of 0.01% and Olmsted County, Minnesota estimated the incidence of BPPV at 0.06%. Increasing number of patients visiting for benign positional vertigo treatment, and its growing demand exhibits lucrative growth opportunity for the companies operating in the market.
Have Any Query? Ask our Industry Experts- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1292
Benign positional vertigo treatment Market: Regional Outlook
Geographically, the global benign positional vertigo treatment market is segmented into regions viz. North America, Europe, Asia-Pacific excluding Japan, Middle East and Africa and Japan. North America & Europe regions are expected to have healthy growth in terms of revenue due to increased awareness regarding benign positional vertigo treatment as a part of the routine checkups. Besides, the lower cost of the procedure compared with other alternative treatments and low risk associated with the procedure are boosting the growth of benign positional vertigo treatment market in the regions.
Request Methodology of this Report- https://www.factmr.com/connectus/sample?flag=RM&rep_id=1292
Benign positional vertigo treatment Market: Key Players
Examples of some of the players identified in the benign positional vertigo treatment market include AstraZeneca plc., Intas Pharmaceutical Ltd., Cadila Pharmaceuticals, Pfizer Inc., Sanofi S.A., Medichem S.A., Liaoyuan Silver Eagle Pharmaceutical Co., Ltd., LGM Pharma, Marclabs and Sun Pharmaceutical Industries Ltd.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers an exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America ( Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- Europe (Germany, Italy, UK, Spain, France, Russia, Belgium, Netherlands, Luxemburg, Norway, Denmark, Iceland, Sweden, Poland, Ukraine, Czech Rep, Rest of Europe)
- Asia Pacific Excluding Japan (India, Australia & New Zealand, Greater China, S. Korea, ASEAN Countries, Rest of APEJ)
- CIS & Russia
- Middle East and Africa (GCC, Turkey, Iran, Israel, South Africa, Rest Of MEA)
- A detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.